Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Valneva
(https://valneva.com) 📸 Data Snapshot: May 28, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE Home – Valneva (https://valneva.com)
Home – Valneva
We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs.
NAV_HEADER_HEADING_REPEATED_BODY_FOOTER Careers – Valneva (https://valneva.com/careers/)
Careers – Valneva
Our achievements are based on our Company's culture, which is characterized by respect, dedication and motivation.
NAV_HEADER_HEADING_REPEATED_BODY_FOOTER About Us – Valneva (https://valneva.com/about-us/)
About Us – Valneva
We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs.
NAV_HEADER_REPEATED_FOOTER Products – Valneva (https://valneva.com/products/)
Products – Valneva
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE · THIN (https://valneva.com) Home – Valneva
We’re Hiring We’re Hiring [H2] Advancing Vaccines For Better Lives [H2] Welcome to Valneva We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. We have leveraged our expertise and capabilities both to commercialize three vaccines, including a single-shot chikungunya vaccine, and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, Shigella and Zika. Learn More [H2] Check out our 2025 Annual Business Report Learn More [H2] Press Releases View More [H2] Follow Us
SUB-PAGE (https://valneva.com/careers/) Careers – Valneva
Job Openings Our achievements are based on our Company's culture, which is characterized by respect, dedication and motivation. [H2] We are Valneva Kirsty, Quality Control Analytical Manager Valneva offers opportunities for long-term growth. I've been with the Company for a decade - progressing from Analyst to Quality Control Analytical Manager. Quality Control is an incredibly fulfilling career, which involves working across the whole business to ensure the products we produce are safe and effective Toyin, Junior Scientist, Analytical Development Seeing first-hand the devastation caused by the lack of vaccines or medicines, the need to reduce the impact of diseases in our world became a purpose for me. I chose a career that enables me to be a part of the solution. I remain inspired as a scientist, knowing that every effort counts for the lives of those in my communities and the rest of the world. Christoph, Technical Assistant Clinical Trial Material Analytics The vaccines we are working on could potentially help prevent disease and suffering in the future. Our team is making sure that clinical trial vaccines are effective, stable and safe Vera, Head of Clinical Operations, Lyme Disease Vaccine Development I am leading teams responsible for managing clinical studies for our vaccine candidates. It is truly exciting to watch our programs develop and I am glad to be working with such great people Robert, Director of Manufacturing Operations It is a pleasure to work with these talented people at Valneva in Sweden, where we are providing full fill and finish operations for vaccines Valneva’s success stems from the dedication and expertise of more than 650 employees. Valneva is an international company that prides itself in providing its workforce the opportunity for personal growth and development, while encouraging work-life balance. As a global company that respects all cultures, we are convinced that the rich diversity of our colleagues makes us more innovative, effective and competitive. Our Sustainability Report [H2] Together we thrive Pablo Senior Project Manager Adrianne Associate Market Access Manager Jana Clinical Operations Manager Michael Senior Technical Assistant Quality Control Analytics Zsuzsanna Director Pharmacovigilance & QPPV View More × × × × × [H2] Current Job Openings [H2] Valneva Locations Austria Canada France France Sweden U.K. U.K. U.S.A. [H3] Valneva has operations in Austria, Sweden, the United Kingdom, France, Canada and the U.S. [H2] Austria [H4] Vienna VALNEVA Austria GmbH Campus Vienna Biocenter 3 1030 Vienna, Austria T: +43 1 20620 F: +43 1 20 620 800 Contact Us [H2] Canada [H4] Montreal Commercial Operations 3535 Saint-Charles Blvd., Suite 600 Kirkland, Québec H9H 5B9 Canada T: +1 514 630 6999 F: +1 514 630 9666 Contact Us [H2] France [H4] Lyon Ilot Saint-Joseph Bureaux Convergence Bâtiment A 12 ter quai Perrache 69 002 Lyon, France T: +33 4 78 76 61 01 F: +33 4 43 86 63 30 Contact Us [H4] Nantes 6 rue Alain Bombard 44800 Saint-Herblain France T: +33 22 807 37 10 F: +33 228 07 37 11 [H2] Sweden [H4] Solna VALNEVA Sweden AB SE – 105 21 Stockholm, Sweden Visiting Address: Gunnar Asplunds allé 16 171 69 Solna, Sweden T: +46 (0)8 121 015 00 [H2] U.K. [H4] Livingston Valneva Scotland Ltd. Oakbank Park Road Livingston EH53 0TG Scotland T: +44 1506 446 600 F: +44 1506 446 601 Contact Us [H4] Fleet Valneva UK Ltd Sentinel House Ancells Business Park, Harvest Crescent Fleet, GU51 2UZ United Kingdom T: +44 1252 761007 [H2] U.S.A. [H4] Bethesda Valneva USA, Inc. 4550 Montgomery Ave., Suite 460 Bethesda, MD 20814, USA T: +1 301 556 4500 Contact Us
SUB-PAGE · THIN (https://valneva.com/about-us/) About Us – Valneva
We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. Our vision is to live in a world in which no one dies or suffers from a vaccine-preventable disease. [H2] Valneva at a glance [H2] 3 Commercial vaccines [H2] €~174.7m Total revenues in 2025 [H2] 3 Unique vaccine development programs [H2] Integrated differentiated clinical and pre-clinical assets robust commercial portfolio [H2] Focused on prevention of infectious diseases with significant unmet medical need [H2] >650 employees in six countries
SUB-PAGE · THIN (https://valneva.com/products/) Products – Valneva
Protecting travelers with innovative vaccines [H2] Our Products Physicians, pharmacists and other healthcare professionals will find information about our products here: Learn more [H2] Marketing and Distribution Valneva has a specialist commercial capability for the distribution of its travelers’ vaccines in key travel vaccine markets. Learn more [H2] Manufacturing and Services Valneva’s global manufacturing network includes three in-house operations to cover the internal and external production of clinical and commercial products. Learn more
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 3 | 2 |
| /careers/ | 3 | 1 |
| /about-us/ | 3 | 1 |
| /products/ | 1 | 1 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage schema
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://valneva.com/",
"url": "https://valneva.com/",
"name": "Home - Valneva",
"isPartOf": {
"@id": "https://valneva.com/#website"
},
"datePublished": "2019-06-03T15:22:35+00:00",
"dateModified": "2026-03-18T05:52:29+00:00",
"description": "We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs.",
"breadcrumb": {
"@id": "https://valneva.com/#breadcrumb"
},
"inLanguage": "en-US",
"potentialAction": [
{
"@type": "ReadAction",
"target": [
"https://valneva.com/"
]
}
]
},
{
"@type": "BreadcrumbList",
"@id": "https://valneva.com/#breadcrumb",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home"
}
]
},
{
"@type": "WebSite",
"@id": "https://valneva.com/#website",
"url": "https://valneva.com/",
"name": "Valneva",
"description": "",
"potentialAction": [
{
"@type": "SearchAction",
"target": {
"@type": "EntryPoint",
"urlTemplate": "https://valneva.com/?s={search_term_string}"
},
"query-input": {
"@type": "PropertyValueSpecification",
"valueRequired": true,
"valueName": "search_term_string"
}
}
],
"inLanguage": "en-US"
}
]
}
/careers/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://valneva.com/careers/",
"url": "https://valneva.com/careers/",
"name": "Careers - Valneva",
"isPartOf": {
"@id": "https://valneva.com/#website"
},
"datePublished": "2019-06-03T15:57:15+00:00",
"dateModified": "2026-04-01T15:05:01+00:00",
"description": "Our achievements are based on our Company's culture, which is characterized by respect, dedication and motivation.",
"breadcrumb": {
"@id": "https://valneva.com/careers/#breadcrumb"
},
"inLanguage": "en-US",
"potentialAction": [
{
"@type": "ReadAction",
"target": [
"https://valneva.com/careers/"
]
}
]
},
{
"@type": "BreadcrumbList",
"@id": "https://valneva.com/careers/#breadcrumb",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://valneva.com/"
},
{
"@type": "ListItem",
"position": 2,
"name": "Careers"
}
]
},
{
"@type": "WebSite",
"@id": "https://valneva.com/#website",
"url": "https://valneva.com/",
"name": "Valneva",
"description": "",
"potentialAction": [
{
"@type": "SearchAction",
"target": {
"@type": "EntryPoint",
"urlTemplate": "https://valneva.com/?s={search_term_string}"
},
"query-input": {
"@type": "PropertyValueSpecification",
"valueRequired": true,
"valueName": "search_term_string"
}
}
],
"inLanguage": "en-US"
}
]
}
/about-us/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://valneva.com/about-us/",
"url": "https://valneva.com/about-us/",
"name": "About Us - Valneva",
"isPartOf": {
"@id": "https://valneva.com/#website"
},
"datePublished": "2019-06-03T15:55:13+00:00",
"dateModified": "2026-03-31T10:02:42+00:00",
"description": "We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs.",
"breadcrumb": {
"@id": "https://valneva.com/about-us/#breadcrumb"
},
"inLanguage": "en-US",
"potentialAction": [
{
"@type": "ReadAction",
"target": [
"https://valneva.com/about-us/"
]
}
]
},
{
"@type": "BreadcrumbList",
"@id": "https://valneva.com/about-us/#breadcrumb",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://valneva.com/"
},
{
"@type": "ListItem",
"position": 2,
"name": "About Us"
}
]
},
{
"@type": "WebSite",
"@id": "https://valneva.com/#website",
"url": "https://valneva.com/",
"name": "Valneva",
"description": "",
"potentialAction": [
{
"@type": "SearchAction",
"target": {
"@type": "EntryPoint",
"urlTemplate": "https://valneva.com/?s={search_term_string}"
},
"query-input": {
"@type": "PropertyValueSpecification",
"valueRequired": true,
"valueName": "search_term_string"
}
}
],
"inLanguage": "en-US"
}
]
}
/products/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://valneva.com/products/",
"url": "https://valneva.com/products/",
"name": "Products - Valneva",
"isPartOf": {
"@id": "https://valneva.com/#website"
},
"datePublished": "2024-12-16T16:44:35+00:00",
"dateModified": "2025-07-18T13:03:13+00:00",
"breadcrumb": {
"@id": "https://valneva.com/products/#breadcrumb"
},
"inLanguage": "en-US",
"potentialAction": [
{
"@type": "ReadAction",
"target": [
"https://valneva.com/products/"
]
}
]
},
{
"@type": "BreadcrumbList",
"@id": "https://valneva.com/products/#breadcrumb",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://valneva.com/"
},
{
"@type": "ListItem",
"position": 2,
"name": "Products"
}
]
},
{
"@type": "WebSite",
"@id": "https://valneva.com/#website",
"url": "https://valneva.com/",
"name": "Valneva",
"description": "",
"potentialAction": [
{
"@type": "SearchAction",
"target": {
"@type": "EntryPoint",
"urlTemplate": "https://valneva.com/?s={search_term_string}"
},
"query-input": {
"@type": "PropertyValueSpecification",
"valueRequired": true,
"valueName": "search_term_string"
}
}
],
"inLanguage": "en-US"
}
]
}
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
Based on 784 businesses audited.
Valneva has 10.7 points less BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: Valneva (valneva.com)
Valneva is a low-BS entity that prioritizes factual corporate reporting and specific product pipeline updates over generic healthcare platitudes. The high substance levels in financial and R&D reporting offset minor technical SEO failures and standard industry jargon.
Add a descriptive H1 to the homepage containing the brand name and core value proposition to fix the technical authority gap. Implement Organization and Person schema to link named leadership and scientific staff to their professional digital footprints. Replace generic [H2] headers like ‘3’ and ‘>650’ with descriptive headings that include the metric (e.g., ‘Commercialized Vaccine Portfolio’). Provide direct links to peer-reviewed clinical trial data on the Products page to strengthen the proof path.
The website content perfectly aligns with the Pharma and Biotech industry. It focuses on prophylactic vaccines, clinical trial development for specific diseases (Lyme, Chikungunya, Zika), and regulatory-adjacent reporting like financial results and annual business reports.
“The score of 30 was driven by strong Information Density and low Semantic Drift, but penalized slightly by Identity and Authority gaps (technical implementation) and standard Industry Cliché density. The site ranks in the 'Low BS' category because it backs 2025/2026 claims with hard financial and scientific specifics.”
This training module utilizes a snapshot of public data from Valneva, captured on May 28, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to Valneva: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://valneva.com to view the most current version of its content and learn from the source what this company is about and what it offers.